Home Antibody All anti-RCL antibodies
Anti-RCL Antibody EPR8686
|A synthetic peptide corresponding to residues in human RCL was used as an immunogen.|
||0.5~1.0 mg/ml (Lot Dependent)
|WB, ASSAY, IHC
||WB: 1:10000 - 1:50000; IP: 1:10 - 1:100; IHC-P: 1:100 - 1:250; ICC: 1:100 - 1:250; FC: 1:10 - 1:100
Preservative: 0.01% Sodium azide
Constituents: 49% PBS, 50% Glycerol, 0.05% BSA
|Tissue culture supernatant
|Does not react with Mouse, Rat
|Homo sapiens 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (DNPH1), transcript variant 1|
|C6orf108; dJ330M21.3; RCL|
|RCL was identified on the basis of its stimulation by c-Myc protein. The latter is a transcription factor that participates in the regulation of cell proliferation, differentiation, and apoptosis. The exact function of RCL is not known, but studies in rat suggest a role in cellular proliferation and c-Myc-mediated transformation (1). |
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot - Anti-RCL antibody [EPR8686]; All lanes : Anti-RCL antibody [EPR8686] at 1/10000 dilution.Lane 1 : K562 cell lysate.Lane 2 : HepG2 cell lysate.Lane 3 : HeLa cell lysate.Lane 4 : Jurkat cell lysate.Lane 5 : MCF7 cell lysate.Lysates/proteins at 10 µg per lane.Secondary.HRP labelled Goat anti Rabbit IgG at 1/2000 dilution.Predicted band size : 19 kDa.
Other-Anti-RCL antibody [EPR8686](TA310818); Equilibrium disassociation constant (KD)..
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RCL antibody [EPR8686]; Immunohistochemical analysis of paraffin embedded Human breast carcinoma tissue labelling RCL with TA310818 antibody at 1/100 dilution.